Immunological safety and sensitizing effect of an MB-7-based vaccine against hepatitis A
Smerdova, M.A.; Usova, S.V.; Smolina, M.P.; Netesov, S.V.; Maĭdaniuk, A.G.; Muntianova, M.A.; Nemtsov, I.V.; Kriuk, N.I.; Iashin, V.V.; Karpovich, L.G.; Kalashnikova, T.V.
Voprosy Virusologii 49(5): 17-21
2004
ISSN/ISBN: 0507-4088 PMID: 15529858 Document Number: 575516
The influence of a vaccine based on the MB-7 strain of hepatitis A virus (VP-MB-7) designed at the "Vector" Center of Virology and Biotechnology was studied. VP-MB-7 was found to provoke no allergic response and to have an activating effect on the specific and non-specific responses of cell and humoral immunity similar to those evoked by hepatitis A vaccine "Hep-A-in Vac".
Document emailed within 1 workday
Related Documents
Chuĭkova, K.I.; Gordetskaia, E.L.; Gorbunov, M.A.; Maĭdaniuk, A.G.; Pomytkina, M.I. 2006: The immunological effectiveness and reactogenicity of the vaccine "HEP-A+B-in-VAC" against hepatitis a and B Voprosy Virusologii 51(1): 31-33Liu, H.-F.; Zhang, X.-J.; Zhang, J.-L.; Hao, Z.-Y.; Zhang, Z.-Y.; Ma, J.-C.; Chen, J.-C.; Chu, J.; Wang, X.-Y.; Xu, Z.-Y. 2009: The immunological effects of three doses of a live attenuated hepatitis a vaccine (H2 strain) in 8 years Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(3): 180-181
Jafarzadeh, A.; Montazerifar, S.J. 2006: Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth Journal of Ayub Medical College Abbottabad: Jamc 18(4): 4-9
1982: Hepatitis B virus vaccine safety: report of an inter-agency group Mmwr. Morbidity and Mortality Weekly Report 31(34): 465-467
Kaufmann, R.; Mondorf, A.W.; Uthemann, H.; Bauer, H.; Prince, A.M. 1983: Hepatitis B vaccine: safety study in anti-HBs seronegative human volunteers Developments in Biological Standardization 54: 229-235
Lee, C.Y.; Huang, L.M.; Lee, P.I.; Chiu, H.H.; Dumas, R.; Milcamps, B.; Lin, W. 2000: Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children Southeast Asian Journal of Tropical Medicine and Public Health 31(1): 29-36
Shi, J.; Li, Z.; Zheng, L. 2001: Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine (YDV) on adults Zhonghua Liu Xing Bing Xue Za Zhi 22(2): 105-107
Kuvakina, V.I.; Golovina, L.I.; Mishina, A.I.; Skirda, T.A.; Bobyleva, G.V.; Mikheeva, N.G.; Chernyshova, T.F.; Temper, R.M.; Ermolenko, Z.N. 2002: Evaluation of the immunological activity and safety of group B meningococcal vaccine prepared from a natural complex of specific polysaccharide and outer membrane proteins Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 33-37
Shah, R.; Raghu, M.B.; Shivananda, A.; Mangayarkarasi, S.; Rao, I.; Rao, R.; Bhusari, P.; Joseph, C.A.; Reddy, R. 2008: Immunogenicity and safety of an indigenously developed DTPw hepatitis B combination vaccine in Indian infants Indian Pediatrics 45(10): 819-823
Schiff, G.M.; Sherwood, J.R.; Zeldis, J.B.; Krause, D.S. 1995: Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 16(1): 12-17
Fu, Q.-p.; He, H.; Li, L.; Chen, H.-p.; Zeng, Y.-x.; Liu, Q.-l.; Fang, G.; Dong, C.-m.; Guo, S.-h.; Li, H.-g.; Wang, H.-y.; He, C.-s.; Zhou, S.-z.; Li, L.; Gu, S.-n.; Zhang, Z.-f.; Dai, M. 2009: The immunogenicity and safety of 10 microg recombination yeast hepatitis B vaccine applied in expanded population Zhonghua Yu Fang Yi Xue Za Zhi 43(10): 903-906
Vasil'eva, O.A.; Peretrukhina, A.T.; Meniavtseva, T.A. 1977: Sensitizing properties of smallpox vaccine Voprosy Virusologii 3: 324-326
Bulkow, L.R.; McMahon, B.J.; Wainwright, R.B.; Parkinson, A.J.; Wainwright, K.Y.; House, J. 1993: Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine formulation in healthy adults Arctic Medical Research 52(3): 118-126
Joshi, N.; Kumar, A.; Raghu, M.B.; Bhave, S.; Arulprakash, R.; Bhusari, P.; Rao, R. 2004: Immunogenicity and safety of hepatitis B vaccine (Shanvac-B) using a novel pre-filled single use injection device Uniject in Indian subjects Indian Journal of Medical Sciences 58(11): 472-477
Ricciardi, G.; Graziano, G. 1990: Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel Bollettino dell'Istituto Sieroterapico Milanese 69(2): 385-390
Wilson, S.; Aprile, M.A. 1970: Sensitizing versus immunizing properties of inactivated measles vaccine Progress in Immunobiological Standardization 4: 657-660
Yuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
Van Oirschot, J.T.; Terpstra, C.; Moormann, R.J.; Berns, A.J.; Gielkens, A.L. 1990: Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein i Veterinary Record 127(18): 443-446
Huu, T.Ngoc.; Phuong, N.Thi.Minh.; Toan, N.Trong.; Thang, H.Vinh. 2015: Immunogenicity and Safety of Quinvaxem® (Diphtheria, Tetanus, Whole-Cell Pertussis, Hepatitis B and Haemophilus Influenzae Type B Vaccine) Given to Vietnamese Infants at 2 to 4 Months of Age Southeast Asian Journal of Tropical Medicine and Public Health 46(4): 753-763
Yap, I.; Chan, S.H. 1996: A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: a preliminary observation Annals of the Academy of Medicine Singapore 25(1): 120-122